RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

NCT04776265 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma, Adult
Relapsed Hodgkin's Disease, Adult
Refractory Hodgkin Lymphoma

Interventions

OTHER: Evaluation of therapeutical approach after ASCT

Sponsor

Grupo Argentino de Tratamiento de la Leucemia Aguda

Collaborators

[object Object]